Financial statements Optima Medycyna
Balance sheet data of OPTIMA MEDYCYNA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 17 556 037,45 | 20 919 619,73 | 17 393 723,10 | 23 236 239,61 | 23 904 846,49 | 33 421 549,50 |
| A. Fixed assets | 12 306 701,26 | 13 825 466,33 | 12 934 456,32 | 15 288 870,14 | 17 775 713,13 | 29 114 594,49 |
| B. Current assets | 5 249 336,19 | 7 094 153,40 | 4 459 266,78 | 7 947 369,47 | 6 129 133,36 | 4 306 955,01 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 17 556 037,45 | 20 919 619,73 | 17 393 723,10 | 23 236 239,61 | 23 904 846,49 | 33 421 549,50 |
| A. Equity | 9 686 391,15 | 11 774 898,58 | 13 463 542,68 | 17 624 111,64 | 19 868 724,26 | 28 794 735,37 |
| B. Liabilities and provisions for liabilities | 7 869 646,30 | 9 144 721,15 | 3 930 180,42 | 5 612 127,97 | 4 036 122,23 | 4 626 814,13 |
| I. Long-term liabilities | 3 419 512,07 | 3 221 455,41 | 104 039,00 | 986 679,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 3 355 642,50 | 2 598 696,64 | 2 306 712,18 | 3 343 275,33 | 2 889 073,48 | 3 382 360,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.